Night

2021-06-30

Night

Altimmune stock falls after it drops development of nasal COVID-19 vaccine

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

IsaacYap90
2021-06-30
IsaacYap90
Altimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated.
- 1Man2Stonks:
  sigh..

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":153339027,"tweetId":"153339027","gmtCreate":1625009426769,"gmtModify":1703849865002,"author":{"id":3576990637797737,"idStr":"3576990637797737","authorId":3576990637797737,"authorIdStr":"3576990637797737","name":"1Man2Stonks","avatar":"https://static.tigerbbs.com/2c93182b4ac6670e37860fa9cbdfd2d4","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":54,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Night</p></body></html>","htmlText":"<html><head></head><body><p>Night</p></body></html>","text":"Night","highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/153339027","repostId":2147603368,"repostType":4,"repost":{"id":"2147603368","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1625009040,"share":"https://www.laohu8.com/m/news/2147603368?lang=&edition=full","pubTime":"2021-06-30 07:24","market":"us","language":"en","title":"Altimmune stock falls after it drops development of nasal COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2147603368","media":"Dow Jones","summary":"MW Altimmune stock falls after it drops development of nasal COVID-19 vaccine\nAltimmune Inc. $(ALT)$","content":"<p>MW Altimmune stock falls after it drops development of nasal COVID-19 vaccine</p>\n<p>Altimmune Inc. <a href=\"https://laohu8.com/S/ALT\">$(ALT)$</a> shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated. Altimmune shares fell 33% after hours, following a 2.5% decline to close at $15.90. The company called study results of its AdCOVID vaccine \"disappointing\" and said it would focus on its treatments for obesity and liver disease. \"Although antibodies were detected that bound the SARS-CoV-2 Spike protein and neutralized the virus in a subset of subjects, the magnitude of the response and the percent of subjects responding to AdCOVID were substantially lower than what had been demonstrated for other vaccines already authorized for emergency use,\" Altimmune said in a statement. Shares had gained 53% over the past 12 months, compared with a 41% gain on the S&amp;P 500 index .</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Altimmune stock falls after it drops development of nasal COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAltimmune stock falls after it drops development of nasal COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-30 07:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Altimmune stock falls after it drops development of nasal COVID-19 vaccine</p>\n<p>Altimmune Inc. <a href=\"https://laohu8.com/S/ALT\">$(ALT)$</a> shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated. Altimmune shares fell 33% after hours, following a 2.5% decline to close at $15.90. The company called study results of its AdCOVID vaccine \"disappointing\" and said it would focus on its treatments for obesity and liver disease. \"Although antibodies were detected that bound the SARS-CoV-2 Spike protein and neutralized the virus in a subset of subjects, the magnitude of the response and the percent of subjects responding to AdCOVID were substantially lower than what had been demonstrated for other vaccines already authorized for emergency use,\" Altimmune said in a statement. Shares had gained 53% over the past 12 months, compared with a 41% gain on the S&amp;P 500 index .</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147603368","content_text":"MW Altimmune stock falls after it drops development of nasal COVID-19 vaccine\nAltimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated. Altimmune shares fell 33% after hours, following a 2.5% decline to close at $15.90. The company called study results of its AdCOVID vaccine \"disappointing\" and said it would focus on its treatments for obesity and liver disease. \"Although antibodies were detected that bound the SARS-CoV-2 Spike protein and neutralized the virus in a subset of subjects, the magnitude of the response and the percent of subjects responding to AdCOVID were substantially lower than what had been demonstrated for other vaccines already authorized for emergency use,\" Altimmune said in a statement. Shares had gained 53% over the past 12 months, compared with a 41% gain on the S&P 500 index .","news_type":1},"isVote":1,"tweetType":1,"viewCount":25,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":5074086,"commentId":"5074086","gmtCreate":1625010486270,"gmtModify":1663230308037,"authorId":3583568085402852,"author":{"id":3583568085402852,"idStr":"3583568085402852","authorId":3583568085402852,"name":"IsaacYap90","avatar":"https://static.tigerbbs.com/40f66d0266826bb209ee22688d7bbde5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":153339027,"objectIdStr":"153339027","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Altimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated.","text":"Altimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated.","html":"Altimmune Inc. $(ALT)$ shares dropped in the extended session Tuesday after the biotech said it was discontinuing study of a COVID-19 nasal spray vaccine because it didn't work as well as anticipated.","likeSize":1,"commentSize":1,"subComments":[{"id":5076983,"commentId":"5076983","gmtCreate":1625025376573,"gmtModify":1663230317039,"authorId":3576990637797737,"author":{"id":3576990637797737,"idStr":"3576990637797737","authorId":3576990637797737,"name":"1Man2Stonks","avatar":"https://static.tigerbbs.com/2c93182b4ac6670e37860fa9cbdfd2d4","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":153339027,"objectIdStr":"153339027","type":1,"supId":5074086,"supIdStr":"5074086","prevId":0,"prevIdStr":"0","content":"sigh..","text":"sigh..","html":"sigh.."}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/153339027"}